Compugen Ltd. (CGEN) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Compugen Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.415 Ladies and gentlemen, thank you for joining us today. 00:00:03.415 -- 00:00:07.199 Welcome to CompliGen's first quarter 2026 results 00:00:07.199 -- 00:00:12.525 conference call. At this time, all participants are in listen-only mode. 00:00:12.525 -- 00:00:17.550 An audio webcast of this call is available in the Investors section of CompliGen's 00:00:17.550 -- 00:00:21.733 website at www.cgen.com. 00:00:22.135 -- 00:00:25.519 As a reminder, today's call is being recorded. 00:00:25.519 -- 00:00:30.665 I will now hand the call over to Lindsay Trickett, Head of Investor Relations and 00:00:30.665 -- 00:00:35.633 Corporate Communications, to begin. Lindsay, please go ahead. 00:00:35.633 -- 00:00:40.140 Thank you, Operator. Good morning and good afternoon, everyone, and welcome to Compusion's 00:00:40.140 -- 00:00:44.266 first quarter 2026 Financial Results Conference call. 00:00:44.266 -- 00:00:49.354 With us today are Dr. Aaron Ophir, President and Chief Executive Officer, and 00:00:49.354 -- 00:00:52.419 David Silberman, Chief Financial Officer. Dr. 00:00:52.419 -- 00:00:57.541 Michelle Mahler, Chief Medical Officer, will join us for the Q&A portion of the call. 00:00:57.541 -- 00:01:02.507 Before we begin, I'd like to remind you that during this call, the company may make projections 00:01:02.507 -- 00:01:07.413 or forward-looking statements regarding future events, business outlook, development 00:01:07.413 -- 00:01:12.459 efforts and their potential outcome, the company's discovery platform, anticipated 00:01:12.459 -- 00:01:17.705 progress and plans, results and timelines for our programs, including disclosure 00:01:17.705 -- 00:01:22.751 of clinical data, financial and accounting-related matters, as well as statements regarding ...